A Phase II Trial of Carboplatin and Gemcitabine with Exisulind (IND #65,056) in Patients with Advanced Non-small Cell Lung Cancer: An Eastern Cooperative Oncology Group Study (E1501)

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

A Phase II Trial of Carboplatin and Gemcitabine with Exisulind (IND #65,056) in Patients with Advanced Non-small Cell Lung Cancer: An Eastern Cooperative Oncology Group Study (E1501)

Journal of Thoracic Oncology ◽

10.1016/s1556-0864(15)30380-4 ◽

2006 ◽

Vol 1 (7) ◽

pp. 673-678

Author(s):

Gregory A. Masters ◽

Sigui Li ◽

Afshin Dowlati ◽

Stefan Madajewicz ◽

Corey Langer ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Phase II trial of acivicin versus etoposide-cisplatin in non-small cell lung cancer: An Eastern Cooperative Oncology Group study

Lung Cancer ◽

10.1016/0169-5002(95)96460-d ◽

1995 ◽

Vol 12 (1-2) ◽

pp. 155

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

A Phase II trial of carboplatin and vindesine in patients with non-small cell lung cancer. A Hellenic Cooperative Oncology Group study

Lung Cancer ◽

10.1016/0169-5002(93)90312-l ◽

1993 ◽

Vol 10 (1-2) ◽

pp. 85-89

Author(s):

Nicholas A. Pavlidis ◽

George Klouvas ◽

Costas Nicolaides ◽

Apostolos Karantanas ◽

Marios Beer ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Phase II trial of high-dose cisplatin plus etoposide plus vinblastine in non-small-cell lung cancer. A hoosier oncology group study

Lung Cancer ◽

10.1016/0169-5002(92)90206-y ◽

1992 ◽

Vol 8 (2) ◽

pp. 139

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

High Dose ◽

Oncology Group ◽

Small Cell Lung ◽

Phase II study of N-methylformamide, spirogermanium, and 4-demethoxydaunorubicin in the treatment of non-small cell lung cancer (EST 3583): An Eastern cooperative oncology group study

Medical and Pediatric Oncology ◽

10.1002/mpo.2950170306 ◽

1989 ◽

Vol 17 (3) ◽

pp. 197-201 ◽

Cited By ~ 10

Author(s):

David S. Ettinger ◽

Dianne M. Finkelstein ◽

Ross C. Donehower ◽

Alex Y. C. Chang ◽

Michael Green ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Phase II study of N-methylformamide, spirogermanium, and 4-demethoxydaunorubicin in the treatment of non-small cell lung cancer (EST 3583): An Eastern Cooperative Oncology Group Study

Lung Cancer ◽

10.1016/0169-5002(90)90355-p ◽

1990 ◽

Vol 6 (1-2) ◽

pp. 58-59

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

A phase II trial of carboplatin and gemcitabine with exisulind (IND # 65,056) in patients with advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Trial 1501

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.7037 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7037-7037 ◽

Cited By ~ 1

Author(s):

G. A. Masters ◽

R. Xu ◽

C. Langer ◽

A. Dowlati ◽

S. Madajewicz ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Group Trial

A phase II trial of carboplatin and gemcitabine with exisulind (IND # 65,056) in patients with advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Trial 1501

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7037 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7037-7037 ◽

Cited By ~ 4

Author(s):

G. A. Masters ◽

R. Xu ◽

C. Langer ◽

A. Dowlati ◽

S. Madajewicz ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Group Trial

Phase II trial of daily oral VP-16 in refractory small cell lung cancer: a Hoosier Oncology Group study

Lung Cancer ◽

10.1016/0169-5002(90)90231-a ◽

1990 ◽

Vol 6 (3-4) ◽

pp. 140

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Dosing to rash: A phase II trial of the first-line erlotinib for patients with advanced non-small-cell lung cancer an Eastern Cooperative Oncology Group Study (E3503)

European Journal of Cancer ◽

10.1016/j.ejca.2013.10.006 ◽

2014 ◽

Vol 50 (2) ◽

pp. 302-308 ◽

Cited By ~ 21

Author(s):

J.R. Brahmer ◽

J.W. Lee ◽

A.M. Traynor ◽

M.M. Hidalgo ◽

J.M. Kolesar ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

First Line ◽